The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Emerging Cell-Based Therapies in Chronic Lung Diseases: What About Asthma?
|
|---|---|
| Published in |
Frontiers in Pharmacology, April 2021
|
| DOI | 10.3389/fphar.2021.648506 |
| Pubmed ID | |
| Authors |
Andressa Daronco Cereta, Vinícius Rosa Oliveira, Ivan Peres Costa, João Pedro Ribeiro Afonso, Adriano Luís Fonseca, Alan Robson Trigueiro de Souza, Guilherme Augusto Moreira Silva, Diego A. C. P. G. Mello, Luis Vicente Franco de Oliveira, Renata Kelly da Palma |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 21 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 4 | 19% |
| Professor | 2 | 10% |
| Lecturer | 1 | 5% |
| Other | 1 | 5% |
| Student > Ph. D. Student | 1 | 5% |
| Other | 1 | 5% |
| Unknown | 11 | 52% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 2 | 10% |
| Arts and Humanities | 1 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
| Business, Management and Accounting | 1 | 5% |
| Nursing and Health Professions | 1 | 5% |
| Other | 2 | 10% |
| Unknown | 13 | 62% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 December 2022.
All research outputs
#4,597,271
of 23,392,375 outputs
Outputs from Frontiers in Pharmacology
#1,993
of 16,881 outputs
Outputs of similar age
#111,040
of 434,720 outputs
Outputs of similar age from Frontiers in Pharmacology
#121
of 869 outputs
Altmetric has tracked 23,392,375 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,881 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,720 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 869 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.